Drug utilization of corticosteroid in post-operative cataract patients at Klinik Mata Utama (KMU) Madura

Riyadatus Solihah*  -  Department of Clinical Pharmacy and Community, STIKes Ngudia Husada, Madura, Indonesia
Rizal Umar Rahmadani  -  Department of Clinical Pharmacy and Community, STIKes Ngudia Husada, Madura, Indonesia
Dianita Rahayu Puspitasari  -  Department of Clinical Pharmacy and Community, STIKes Ngudia Husada, Madura, Indonesia

(*) Corresponding Author
DOI: 10.30659/sainsmed.v14i1.28054

A cataract is contributed to 51% of blindness in the world. Cataract surgery is needed to restore the normal eye function. Therapeutic management post cataract operative is generally carried out 1-4 weeks by administering antibiotics, corticosteroids or NSAIDs by oral or topical routes. Corticosteroids administration increase intraocular pressure (IOP), therefore should be taken into account in post-operative cataract. The aim of this study was to observe the pattern of corticosteroid use in post-cataract surgery patients at the Klinik Mata Utama (KMU) Madura. Observational retrospective research involved 153 patients who consumed corticosteroids during their post operative cataract period. The results showed that 122 patients (79.7%) received combination therapy of topical dexamethasone and oral methylprednisolone, while 31 (20.3%) received combination therapy of topical dexamethasone and oral prednisone. 140 Patients (91,6%) showed good recovery with corticosteroids, and 13 patients (8,4%) experienced the IOP as a side effect of topical corticosteroids. In conclusion, the corticosteroids therapy for post-operative cataract patients should be managed properly to prevent the side effects of increasing IOP.

Keywords: Cataract; Dexamethasone; Methylprednisolone; Prednisone; Intraocular pressure; Surgery

  1. Bobrow, J.C. (2011). Lens and Cataract. American Academy of Ophthalmology, United States of America, 5-74.
  2. Comstock, T.L, Paterno, M.R., Singh, A., Erb, T., and Davis, E. (2011). Safety and efficacy of loteprednol etabonate ophthalmic ointment 0.5% for the treatment of inflammation and pain following cataract surgery. Clinical Ophthalmology, 5(1): 177–186. Doi: 10.2147/OPTH.S16832.
  3. Flesner, P., Andresen, J. L. and Hjortdal, J. (2014). Post-cataract prevention of inflammation and macular edema by steroid and non-steroidal anti-inflammatory eye drops: A systematic review. Ophthalmology, 121(10): 1915–1924. Doi: 10.1016/j.ophtha.2014.04.035.
  4. Grzybowski, A. and Stephen Jae, K. (2016). Corticosteroids substituted by non-steroidal anti-inflammatory drugs: Is it justified by evidence-based medicine? Journal of Cataract & Refractive Surgery, 42(3): 510–511. Doi: 10.1016/j.jcrs.2016.02.028.
  5. Gupta, V., Rajagopala, M. and Ravishankar, B. (2014). Etiopathogenesis of cataract: An appraisal. Indian Journal of Ophthalmology, 62(2): 103-110. Doi: 10.4103/0301-4738.121141.
  6. Kindle, T., Ferguson, T., Ibach, M., Greenwood, M., Schweitzer, J., Swan, R., Sudhagoni, R.G, and Berdahl, J.P. (2018). Safety and efficacy of intravitreal injection of steroid and antibiotics in cataract surgery and trabecular micro bypass stent. Journal of Cataract and Refractive Surgery, 44(1): 91–97. Doi: 10.1016/j.jcrs.2017.10.040.
  7. Laurell, C. (2002). Inflammatory response after cataract surgery. Acta Ophthalmologica Scandinavica, 76: 632-633. https://doi.org/10.1034/j.1600-0420.1998.760528.x
  8. Liu, Y.C., Wilkins, M., Kim, T., Malyugin, B., and Mehta, J.S. (2017). Cataracts. The Lancet, 390(10094): 600–612. Doi: 10.1016/S0140-6736(17)30544-5.
  9. Mutiarasari, D and Handayani, F. (2011). Katarak Juvenil. INSPIRASI, Xiv: 37–50.
  10. Pleyer, U., Ursell, P. G. and Rama, P. (2013). Intraocular pressure effects of common topical steroids for post-cataract inflammation: Are they all the same?. Ophthalmology and Therapy, 2(2): 55–72. Doi: 10.1007/s40123-013-0020-5.
  11. Riskesdas. (2013). Riset Kesehatan Dasar. Kementerian Kesehatan Republik Indonesia.
  12. Sen, H.N., Abreu, F.M., Louis, T.A, Sugar, E.A, Altaweel, M.M, Elner, S.G., Holbrook, J.T., Jabs, D.A., Kim, R.Y., Kempen, J. H. (2016). Cataract surgery outcomes in Uveitis: The multicenter uveitis steroid treatment trial, Ophthalmology, 123(1): 183–190. Doi 10.1016/j.ophtha.2015.09.022.
  13. Sheppard, J. D., Comstock, T. L. and Cavet, M. E. (2016). Impact of the topical ophthalmic corticosteroid loteprednol etabonate on intraocular pressure, Advances in Therapy, 33(4): 532–552. Doi: 10.1007/s12325-016-0315-8.
  14. Sherif, Z. and Pleyer, U. (2002). Corticosteroids in ophthalmology: Past – present – future. Ophthalmologica, 216(5): 305-15. Doi: 10.1159/000066189.
  15. Solomon, K.D., Vroman, D.T., Barker, D., and Gehlken, J. (2001). Comparison of ketorolac tromethamine 0.5% and rimexolone 1 % to to control inflammation after cataract extraction Prospective randomized double-masked study. Journal of Cataract & Refractive Surgery, 27(8): 1232-1237. Doi: 10.1016/S0886-3350(00)00832-4.
  16. Tamagawa-Mineoka, R., Yasuoka, N., Ueta, M., and Katoh, N. (2018). Influence of topical steroids on intraocular pressure in patients with atopic dermatitis. Allergology International, 67(3): 388–391. Doi: 10.1016/j.alit.2018.01.004.
  17. World Health Organization (WHO). (2018). Blindness & vision impairment prevention. http://www.who.int/blindness/causes/priority/en/index1.html. Accessed 26 June 2022.
  18. Zhang G, Liu S, Yang L, and Li Y. (2018). The role of dexamethasone in clinical pharmaceutical treatment for patients with cataract surgery. Experimental and Therapeutic Medicine, 15(2): 2177-2181. https://doi.org/10.3892/etm.2017.5639.

Open Access Copyright (c) 2023 Sains Medika : Jurnal Kedokteran dan Kesehatan
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Sains Medika: Jurnal Kedokteran dan Kesehatan
is published by Fakultas Kedokteran Universitas Islam Sultan Agung Semarang, Indonesia.
Jl. Raya Kaligawe Km.4, PO BOX 1054/SM Semarang 50112
Website: https://fkunissula.ac.id/
Email: sainsmedika@unissula.ac.idsainsmedika@unissula.ac.id

ISSN: 2339-093X (Online) | 2085-1545 (Print)
DOI : 10.30659/sainsmed

This work is licensed under a Creative Commons Attribution 4.0 International License

Get a feed by atom here, RRS2 here and OAI Links here

apps